Introduction: it has been an important challenge; how to supply raw materials and select suppliers in the health supply chain. The pharmaceutical industry is part of these challenges, and there is no specific mechanism for selecting pharmaceutical suppliers. There
More
Introduction: it has been an important challenge; how to supply raw materials and select suppliers in the health supply chain. The pharmaceutical industry is part of these challenges, and there is no specific mechanism for selecting pharmaceutical suppliers. Therefore, the aim of this study is to provide a model for evaluating and prioritizing pharmaceutical suppliers for pharmacies. Methods: The research method is descriptive-analytical and a field study; and the statistical population includes a group of managers of Shiraz pharmacies; statistical sample of experienced and expert managers has been selected. The measuring instruments included three researcher-made questionnaires that were provided to the respondents. Data analysis was performed in two descriptive and analytical sections using BOCR structure and fuzzy MCDM method. Weighing the criteria of suppliers, the ranking of suppliers has been done based on the set criteria. Results: According to the confirmation analysis factors, 14 sub-criteria were determined in four main criteria. Weight rankings showed that the first and second priorities of the indicators were "agility and speed (weight 0.111)" and “discounts cost (0.069)". Also, the results obtained from the prioritization of suppliers showed that Daroopakhsh (similarity index 1) and Hejrat (similarity index 076) companies were in the first and second priorities. Conclusion: The results showed factors such as product diversity, low defect, experience and expertise, quality, up-to-date technologies, discount in cost, credit, agility, inspection cost, shipping cost, product price, customer complaints, delay rate and supplier reputation are the most important criteria influencing the selection of drug suppliers.
Manuscript profile
